RAS Life Science Solutions retweeted
See the long-term (lifetime) effects of dapagliflozin in chronic kidney disease: a time-to-event analysis academic.oup.com/ndt/article… @Stenodiabetes @NDTsocial
RAS Life Science Solutions retweeted
Probably it is not perfect and complete, but it just wants to show all the therapeutics improvements achieved for advanced lung cancer in the recent year. This algorithm will be more full (and complicated) at the end of 2020 working all together!! #LCSM
RAS Life Science Solutions retweeted
May this auspicious day bring you joy, happiness and loads of colourful memories! #HappyHoli2019
RAS Life Science Solutions retweeted
Jane Ericisson from Covance sharing survey results -majority of respondents in UK, Germany and Sweden don’t believe current Price assessment mechanisms are adequate for new Gene therapies #ppmaconf – at Amsterdam, The Netherlands
RAS Life Science Solutions retweeted
Replying to @ucb_news
@ucb_news' Daniel Jackson speaks on the importance of creating value to the patient. "We don't traditionally quantify the value of hope." #PPMAConf #healthcare #Pharma #patientvalue #hta
RAS Life Science Solutions retweeted
Pharma companies need to invest in partnerships to acquire capabilities in order to keep pace with the need for personalized medicine. #personalizedmedicine #pharmaciconf @PharmaCIConf
RAS Life Science Solutions retweeted
A very interesting round table discussion on the importance of #patient #adherence by Elise Dal from @UnitherPharma - there is a need for pharma companies to consider patient adherence while developing a drug #pharmaciconf @PharmaCIConf
RAS Life Science Solutions retweeted
There is no “one size fits all” approach when it comes to developing strategies for patient adherence. Patient stratification is important while considering “beyond the pill” initiatives #pharmaciconf @PharmaCIConf #roundtable
RAS Life Science Solutions retweeted
So much invaluable biomedical research sits in journals, without actualizing its potential to improve human health.
Lost without translation.
RAS Life Science Solutions retweeted
FDA Strategizes to Step Up Introduction of Lower-Cost Drugs and NGS onclive.com/publications/onc…
RAS Life Science Solutions retweeted
Combinatorial cancer Immunotherapies by Carl June @WIN_Consortium
RAS Life Science Solutions retweeted
Seeing and experiencing this event in-person is like no other! So much energy, excitement & intelligence all in one cutting-edge meeting. #ASCO18 nitter.gq/asco/status/1004128299…
And just like that, #ASCO18 comes to a close. Thanks to all who made this event an outstanding success! What is your biggest takeaway from the meeting?
RAS Life Science Solutions retweeted
Pembro plus chemo improved OS with 0.62 HR in squamous NSCLC; effect similar with taxol and nab- pac. @WinshipAtEmory #ASC018 #LCSM. Similar HR across different PDL1 exp groups. Will change SOC. – at Chicago, IL
RAS Life Science Solutions retweeted
Very proud that #ASCO18 scientific committee chose our abstract for the plenary session and humbled that our study team selected me to be the presenter.
RAS Life Science Solutions retweeted
Dr Kristin Fröhlich from @ChariteBerlin is talking @BioVaria about a new treatment of #osteoarthritis.































